S&P Global Ratings on Monday said several Asia-Pacific economies could face higher tariffs under the Trump administration, ...

S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

India's equity benchmark indices Sensex and Nifty experienced a significant drop in their early trade on Monday (24 February) ...

India and Japan have a unique opportunity to gain from US tariffs, says Hero Enterprises' Sunil Kant Munjal. He believes ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Speaking at the Conservative Political Action Conference (CPAC) in Washington on Sunday, President Trump alleged that India already benefits from high tariffs on American goods and does not require fi ...

In a move termed as trade tsunami, set to upend international trade dynamics, President Donald Trump has declared an ...

A White House official, providing details of the order, said Trump was directing his administration to consider responsive actions like tariffs "to combat the digital service taxes (DSTs), fines, ...